| Autor: |
Wilson NK; Department of Surgery, University of Cincinnati, Cincinnati, OH.; Department of Pharmacy, Baylor University Medical Center at Dallas, Dallas, TX., Tremblay S; Department of Surgery, University of Cincinnati, Cincinnati, OH.; Veloxis Pharmaceuticals, Inc, Cary, NC., Shields AR; Department of Surgery, University of Cincinnati, Cincinnati, OH.; Department of Surgery, The Christ Hospital, Cincinnati, OH., Woodle ES; Department of Surgery, University of Cincinnati, Cincinnati, OH., Alloway RR; Department of Surgery, University of Cincinnati, Cincinnati, OH., Vinks AA; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.; Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH., Miyagawa B; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.; Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH., Mizuno T; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.; Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH. |
| Abstrakt: |
Competing Interests: E.S.W. received research grants from Bristol-Myers Squibb and Sanofi, and honoraria. R.R.A. received research grants from Bristol-Myers Squibb, Sanofi, and Veloxis and honoraria. A.A.V. received consulting fees from NDA Partners. T.M. received honoraria from Astellas Pharma, Inc, and Chugai Pharmaceutical Co. Ltd. At the time of study conduct, S.T. was a full-time employee of the University of Cincinnati/University of Cincinnati Physicians. At the time of publication, S.T. was a full-time employee of Veloxis Pharmaceuticals. The other authors declare no conflicts of interest. |
